Fimecs is Drug Discovery in Japan that focus on proteasome system business. Founded in 2018. They cover business area such as developer, protein degradation therapeutic, cancer disease, drug, target and disease-relevant protein, natural ubiquitin or proteasome system mechanism.
2018
( 6 years old in 2024 )
Proteasome System
-
26-1, Muraoka-Higashi 2-Chome
Fujisawa, Kanagawa 251-0012
Japan
Private
developerprotein degradation therapeuticcancer diseasedrugtarget and disease-relevant proteinnatural ubiquitin or proteasome system mechanism
* We use standard office opening hours in near Fimecs's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Fimecs is Drug Discovery business from Japan that founded in 2018 (6 years old in 2024), Fimecs business is focusing on Proteasome System.
Fimecs headquarter office and corporate office address is located in 26-1, Muraoka-Higashi 2-Chome Fujisawa, Kanagawa 251-0012 Japan.
Fimecs was founded in Japan.
In 2024, Fimecs is currently focus on proteasome system sector.
Above is snippet of Google Trends for "proteasome system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Fimecs, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
